Table 2 Treatment characteristics
Covariate | Full sample (n = 117) | |
|---|---|---|
Chemotherapy | Concurrent alone | 51 (43.6%) |
Neoadjuvant + concurrent | 44 (37.6%) | |
Neoadjuvant alone | 1 (0.9%) | |
No chemotherapy | 21 (17.9%) | |
Pelvic radiotherapy | Yes | 107 (91%) |
No | 10 (9%) | |
Lipiodol | Yes | 64 (55%) |
No | 53 (45%) | |
Technique | 3D-CRT | 2 (2%) |
4-Field | 27 (23%) | |
IMRT | 76 (65%) | |
VMAT | 12 (10%) | |
CBCT | Yes | 103 (88%) |
No | 14 (12%) | |
Plan | 2-phase | 87 (74%) |
3-phase | 26 (22%) | |
SIB | 4 (3%) | |